News Chan Zuckerberg Initiative to put $250M into new NYC Biohub The Chan Zuckerberg Initiative's new NYC Biohub will develop new bio-engineered immune cells that can aide in early detection of diseases.
Patients Empowering rare disease patient advocacy organisations with ... Komodo Health’s president and co-founder, Web Sun, tells us about his company’s new partnership with the Chan Zuckerberg Initiative (CZI) to improve early diagnosis and advance research of
News NHS "isn't delivering equitable care for rare diseases" A Genetic Alliance UK report claims the NHS is failing to meet the needs of many of the 3.5 million people in the country who live with rare diseases.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.